Alzheimer's Gene: Test Middle-Aged Adults

A recent study indicates that middle-aged adults could benefit from testing for the APOE gene, which is associated with a significant portion of Alzheimer's cases. Researchers observed that carriers of the APOE e4 gene variant experience a more rapid decline in cognitive function after the age of 70, especially those with two copies of the gene. This finding underscores the importance of interventions during midlife.

Scientists propose that targeting individuals with this genetic risk through early counseling and preventive strategies could be beneficial. Lifestyle modifications such as adopting a Mediterranean-style diet, engaging in structured cognitive training, and maintaining regular physical activity are identified as promising methods to attenuate cognitive decline before the onset of dementia. The study followed over 4,000 participants in Taiwan for approximately six years, measuring cognitive function using the Mini-Mental State Examination.

While carrying the APOE e4 gene increases risk, it does not guarantee dementia development. Lifestyle and environmental factors, including smoking and cardiovascular health, also play a crucial role. Experts estimate that a substantial percentage of dementia cases might be preventable or delayed through lifestyle changes and improved screening, emphasizing a proactive approach to brain health.